We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Bring photo ID to vote Check what photo ID you'll need to vote in person in the General Election on 4 July.
Patients with recurring lymphoma, or who have not responded to prior treatments, could access a new bispecific antibody therapy to help treat their condition.
No evidence of supply or harm to patients
The scheme will see the lowest-risk clinical trials processed by the MHRA in less than 14 days.
Patients to receive the latest valproate safety information with every pack, following changes to the Human Medicines Regulations, 2012
Automation is the future for manufacturing stem cells, says the Head of the Medicines and Healthcare products Regulatory Agency’s UK Stem Cell Bank (UKSCB) on its 20th Anniversary.
Parents and carers should talk to their healthcare professional about how to feed colostrum (first milk) safely to their baby.
Almost three years on from the approval in the UK of the first COVID-19 vaccine, the Medicines and Healthcare products Regulatory Agency (MHRA) pays tribute to the scientists who developed the technology behind the mRNA COVID vaccines, Dr Katalin Kariko and Dr Drew Weissman, who today…
For the first time, patients with certain types of advanced or recurrent endometrial cancer could access a treatment shown to slow its progression
Awareness and action regarding increase of suspected adverse event reports following use of intravenous co-amoxiclav (amoxicillin and clavulanic acid) products.
Businesses across the UK will have the opportunity to showcase that their new AI and digital innovations comply with regulatory standards, so they can quickly bring them to market.
The Innovative Devices Access Pathway (IDAP) pilot was launched today by the Department of Health and Social Care (DHSC), Health Technology Wales (HTW), the Medicines and Healthcare products Regulatory Agency (MHRA), the National Health Service England (NHSE), the National Institute for…
The vaccine was approved after it was found to meet the MHRA’s standards of safety, quality and effectiveness.
More information following our investigation into an increase of adverse event reports following the cascade use of intravenous co-amoxiclav (amoxicillin and clavulanic acid) products.
Government invests £200 million of new funding to boost NHS resilience and ensure patients receive the care they need this winter.
A new regional centre to promote Yellow Card reporting has been launched in Belfast today.
…products Regulatory Agency (MHRA).
The vaccine was approved after it was found to meet the UK regulator's standards of safety, quality and effectiveness
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued detailed guidance on the new International Recognition Procedure (IRP) for medicines manufacturers, including how to apply for a medicine licence.…
An investigation by the Criminal Enforcement Unit (CEU) of the Medicines and Healthcare products Regulatory Agency (MHRA) has led to charges being brought against five people from the Wolverhampton area for the illegal supply of prescription-only medicines and controlled drugs.
Second Pharmaceuticals in the Environment (PiE) Group meeting held with continued focus on imidacloprid and fipronil.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).